Cage Pharmaceuticals is a preclinical bio-pharmaceutical company focused on developing treatments for cancer
Cage Pharmaceuticals is a preclinical bio-pharmaceutical company focused on developing treatments for cancer. The company's lead compound, CP-102, is in a Phase 1 clinical study and works by specifically inhibiting tumor glycolysis to target tumor metabolism.